Ligand validation:1GI3

BMZ: 2-(2-HYDROXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE

BMZ is a Ligand Of Interest in 1GI3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1GI3_BMZ_A_246	89%	22%	0.065	0.942	1.72	1.54	7	2	2	0	100%	1.0079
1GI1_BMZ_A_246	88%	16%	0.075	0.95	1.77	1.9	6	2	1	0	100%	1
1GI0_BMZ_A_246	61%	15%	0.106	0.894	1.94	1.85	8	2	2	0	100%	1
1GHX_BMZ_H_246	93%	20%	0.059	0.952	2.07	1.37	6	2	1	0	100%	1.0284
1GI8_BMZ_B_246	88%	19%	0.078	0.954	2.06	1.41	7	2	3	0	100%	1
1GHW_BMZ_H_246	86%	20%	0.075	0.944	1.94	1.43	6	2	3	0	100%	1.0063

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.